New Blood: Former Novartis Exec Transitions to Rubius Therapeutics
New Red-Blood-Cell-Derived Therapies Are Poised to Launch Rubius into the Spotlight.
Improving Human Health: The Promise of Epigenetics
A New Perspective for Genomic Research from Prof. Shankar Balsubramanian
Translating Innovation into Therapies
Antimicrobial Resistance and Drug Commercialization Were Key Topics at the Recent ON Helix Conference in Cambridge, U.K.
Literature Review: Dielectrophoresis to the Fore
Old Methodology Resurrected to Allow Inexpensive Label-Free Separation of Cell Populations
- Chimera Biotec
- Emil-Figge-Str. 76A
- Dortmund , 44227
Chimera Biotec develops and markets solutions for bio-analytical assays based on Imperacer®, an innovative assay system for ultra-sensitive analyte detection. Imperacer® quantitatively detects molecules such as proteins and metabolites in complex biological samples while extending the dynamic range of any immunoassay by orders of magnitude.